Consistent Commercial ExecutionAnalyst continues to stay on the sidelines until there is consistent commercial execution and sales growth.
Market CompetitionThere is skepticism about SENS's ability to gain traction in the CGM market against established competitors, despite the 365-day indication.
Stock Valuation ConcernsSENS shares are considered expensive as they trade at a high multiple of projected sales and the company is burning cash, increasing the risk of dilution.